实用肝脏病杂志 ›› 2014, Vol. 17 ›› Issue (1): 30-33.doi: 10.3969/j.issn.1672-5069.2014.01.009

• 酒精性肝病 • 上一篇    下一篇

他莫昔芬体外促进HepG2细胞脂肪变性观察*

赵斐, 谢萍, 姜佳丽, 张令强, 安威, 展玉涛   

  1. 100730 北京市 首都医科大学附属北京同仁医院消化科(赵斐,姜佳丽,展玉涛); 军事医学科学院放射与辐射医学研究所(谢萍,张令强); 首都医科大学基础医学院细胞生物学系(安威)
  • 收稿日期:2013-10-15 出版日期:2014-02-28 发布日期:2016-04-11
  • 通讯作者: 展玉涛,E-mail: yutaozhan@263.net
  • 作者简介:赵斐,女,26岁,硕士研究生。主要从事非酒精性脂肪性肝病的发病机制研究。E-mail:fayefly.future@163.com
  • 基金资助:
    肝脏保护与再生调节北京市重点实验室课题(2013年资助)

Tamoxifen promotes lipid accumulation in HepG2 cells in vitro

Zhao Fei, Xie Ping, Jiang Jiali   

  1. Department of Gastroenterology,Tongren Hospital,Capital Medical University,Beijing 100730,China
  • Received:2013-10-15 Online:2014-02-28 Published:2016-04-11

摘要: 目的研究他莫昔芬(TAM)对体外培养的HepG2细胞脂肪变性以及脂类代谢调控关键因子表达的影响。方法应用油酸(50 μmol/L)处理HepG2细胞,诱导细胞脂肪变性体外模型,同时给予不同浓度的TAM (5~20 μmol/L)干预72 h;采用油红O染色和甘油三酯含量测定检测HepG2细胞内脂质聚集情况;应用蛋白印迹法检测固醇调节元件结合蛋白-1c(SREBP-1c)、脂肪酸合成酶(FAS)、 硬脂酰辅酶A去饱和酶(SCD)、肉酯软脂酰基转移酶(CPT1)和微粒体甘油三酯转移蛋白(MTP)的表达;采用细胞活性检测试剂盒测定细胞活性。结果在干预72 h后,模型组细胞内甘油三酯含量为(16.53±0.17) mg/100 mg蛋白质,在5 μmol/L TAM处理细胞内甘油三酯含量为(17.77±0.05) mg/100mg蛋白质,与模型组无显著性差异,但在 10 μmol/L和20 μmol/L TAM处理组较模型组分别增加了31%[(21.57±0.16) mg/100 mg蛋白质]和44%[(23.82±0.44) mg/100 mg蛋白质],(P<0.05);TAM上调细胞内SREBP-1c、FAS、SCD和MTP蛋白表达,但并不改变CPT1蛋白表达;TAM在5~20 μmol/L范围内不影响HepG2细胞活性。结论TAM可促进油酸诱导的HepG2细胞脂肪变性,其主要机制可能是通过上调SREBP-1c及其下游基因,如FAS和SCD的表达而增加了脂肪酸的合成。

关键词: HepG2细胞, 他莫昔芬, 脂肪变, 甘油三酯, 脂肪酸合成

Abstract: Objective To investigate the effect of tamoxifen(TAM) on steatosis in HepG2 cells in vitro and on the expression of key regulators involved in lipid metabolism in the cells. Methods A cell model of steatosis was induced in HepG2 cells in vitro with oleic acid(OA) at 50 μmol/L;HepG2 cells were then subjected to different concentrations of TAM(5 to 20 μmol/L) at the presence of OA for 72 h;Intracellular lipid accumulation was assessed by oil red O staining and measurement of triglyceride;The expression of sterol regulatory element-binding protein-1c(SREBP-1c),fatty acid synthase(FAS),steroyl-CoA desaturase(SCD),carnitine palmitoyltransferase 1(CPT1)and mitochondrial trifunctional protein(MTP)was determined by Western blot;Cell viability was detected by cell counting Kit-8 assay. Results After incubation for 72 h,the intracellular triglyceride in control group was(16.53±0.17) mg/100 mg protein,similar to that of cells treated with 5μmol/L TAM,however,the intracellular triglyceride was increased by 31%[(21.57±0.16) mg/100 mg protein] and 44%[(23.82±0.44) mg/100 mg protein] in cells treated with 10 μmol/L and 20 μmol/L of TAM,respectively(P<0.05);TAM treatment(5 to 10 μmol/L)significantly increased the expression of SREBP-1c,FAS,SCD and MTP without affecting the expression of carnitine palmitoyltransferase 1(CPT1) in HepG2 cells;TAM did not affect HepG2 viability. Conclusions TAM promotes OA-induced cell steatosis,probably by up-regulation of SREBP-1c,FAS and SCD,thus increases fatty acid synthesis in the cells.

Key words: HepG 2 cells, Tamoxifen, Steatosis, Triglyceride, Fatty acid synthesis